Gilead Sciences (GILD) Deferred Taxes (2009 - 2026)

Gilead Sciences (GILD) has reported Deferred Taxes for 18 consecutive years, with $179.0 million the latest figure, recorded in Q1 2026.

• Deferred Taxes for Q1 2026 came in at $179.0 million, up 189.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $538.0 million (up 140.76% YoY), and the FY2025 annual result was $160.0 million, up 108.68% from the prior year.
• Deferred Taxes was $179.0 million for Q1 2026 at Gilead Sciences, up from -$122.0 million in the prior quarter.
• Over five years, Deferred Taxes peaked at $659.0 million in Q3 2025 and troughed at -$723.0 million in Q1 2024.
• Average Deferred Taxes over 5 years is -$236.4 million, with a median of -$270.0 million recorded in 2022.
• Year-over-year, Deferred Taxes sank 1016.9% in 2022 and jumped 214.41% in 2025.
• Over 5 years, Deferred Taxes stood at -$338.0 million in 2022, then fell by 9.47% to -$370.0 million in 2023, then dropped by 2.43% to -$379.0 million in 2024, then soared by 67.81% to -$122.0 million in 2025, then surged by 246.72% to $179.0 million in 2026.
• Per Business Quant data, the three most recent Deferred Taxes figures were $179.0 million in Q1 2026, -$122.0 million in Q4 2025, and $659.0 million in Q3 2025.